Interestingly, two recent studies have shown alterations in SERT availability in the caudate-putamen region prior to the establishment of dopaminergic pathology or the onset of motor symptoms in human carriers of mutations associated with genetic PD [11,12], suggesting that the serotonergic dysfunction precedes any dopaminergic alteration. The gene discussed is SLC6A4; the disease is Parkinson disease.